DIA: Driving Insights to Action
Science:Life Sciences
Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders speaks with Alberto Grignolo about patient involvement and engagement, and the future of drug development for rare diseases. Dr. Wong-Rieger is the first DIA Board Member to represent the voice of the patient.
view more
More Episodes
Imaging Data Plus AI “One of the Best Combinations”
2019-06-21
492
2019-06-21
492
Califf: Digitization Will Return Humanity to Medicine
2019-05-31
596
2019-05-31
596
New Sources Changing the Meaning of Evidence?
2019-05-24
515
2019-05-24
515
AI Research Can Optimize Clinical/Operational Effectiveness
2019-05-03
544
2019-05-03
544
Has Joining ICH Accelerated Innovation in China?
2019-05-01
445
2019-05-01
445
Pricing Pitfalls in Prescription Drug Advertising
2019-04-01
392
2019-04-01
392
MID-NET Among PMDA’s First Steps Into RWE
2019-03-25
442
2019-03-25
442
Regulatory Science 2019: Leading or Holding Back Innovation?
2019-03-18
569
2019-03-18
569
23andMe: Information Empowering Patient Action
2019-03-11
344
2019-03-11
344
The Patient’s Most Engaging Question: Why?
2019-02-25
737
2019-02-25
737
EUnetHTA: Post-Launch Critical for Comparative Data
2019-02-15
447
2019-02-15
447
HSA Harmonizing Culture and Science in Singapore
2019-01-28
402
2019-01-28
402
Promoting Patient-Centric Business: MedComm in Latin America
2019-01-22
439
2019-01-22
439
Separate but Equal: Regulatory & Pricing Assessments in EU
2019-01-15
399
2019-01-15
399
Genetics Leading Modern Revolution in Cancer Care
2018-12-17
613
2018-12-17
613
Automation No Substitute for Scientific Leadership
2018-11-20
471
2018-11-20
471
R2D2 & C-17 New Landmarks in Canada’s Collaborative Pathways
2018-10-29
423
2018-10-29
423
Advanced Therapies Moving Upon Combination Platforms
2018-10-11
569
2018-10-11
569
Challenges in Generic Drug Safety & Surveillance
2018-09-25
361
2018-09-25
361
Get this podcast on your
phone, FREE
